Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb;40(2):e3725.
doi: 10.1002/dmrr.3725. Epub 2023 Oct 4.

Phenotyping obesity: A focus on metabolically healthy obesity and metabolically unhealthy normal weight

Rachel Agius  1   2 , Nikolai P Pace  1 , Stephen Fava  1   2
Affiliations
Review

Phenotyping obesity: A focus on metabolically healthy obesity and metabolically unhealthy normal weight

Rachel Agius et al. Diabetes Metab Res Rev. 2024 Feb.

Abstract

Over the past 4 decades, research has shown that having a normal body weight does not automatically imply preserved metabolic health and a considerable number of lean individuals harbour metabolic abnormalities typically associated with obesity. Conversely, excess adiposity does not always equate with an abnormal metabolic profile. In fact, evidence exists for the presence of a metabolically unhealthy normal weight (MUHNW) and a metabolically healthy obese (MHO) phenotype. It has become increasingly recognised that different fat depots exert different effects on the metabolic profile of each individual by virtue of their location, structure and function, giving rise to these different body composition phenotypes. Furthermore, other factors have been implicated in the aetiopathogenesis of the body composition phenotypes, including genetics, ethnicity, age and lifestyle/behavioural factors. Even though to date both MHO and MUHNW have been widely investigated and documented in the literature, studies report different outcomes on long-term cardiometabolic morbidity and mortality. Future large-scale, observational and population-based studies are required for better profiling of these phenotypes as well as to further elucidate the pathophysiological role of the adipocyte in the onset of metabolic disorders to allow for better risk stratification and a personalised treatment paradigm.

Keywords: insulin resistance; metabolic syndrome; metabolically healthy obesity (MHO); metabolically unhealthy normal weight (MUHNW); obesity.

PubMed Disclaimer

References

REFERENCES

    1. Bray GA, Kim KK, Wilding JPH, World Obesity Federation. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev Off J Int Assoc Study Obes. 2017;18(7):715-723. https://doi.org/10.1111/obr.12551
    1. Mechanick JI, Hurley DL, Garvey WT. Adiposity-based chronic disease as a new diagnostic term: the American Association of Clinical Endocrinologists and American College ofndocrinology position statement. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2017;23(3):372-378. https://doi.org/10.4158/ep161688.ps
    1. Frühbeck G, Busetto L, Dicker D, et al. The ABCD of obesity: an EASO position statement on a diagnostic term with clinical and scientific implications. Obes Facts. 2019;12(2):131-136. https://doi.org/10.1159/000497124
    1. Lyall DM, Celis-Morales C, Ward J, et al. Association of body mass index with cardiometabolic disease in the UK Biobank: a Mendelian randomization study. JAMA Cardiol. 2017;2(8):882-889. https://doi.org/10.1001/jamacardio.2016.5804
    1. Lavie CJ, Laddu D, Arena R, Ortega FB, Alpert MA, Kushner RF. Healthy weight and obesity prevention: JACC health promotion series. J Am Coll Cardiol. 2018;72(13):1506-1531. https://doi.org/10.1016/j.jacc.2018.08.1037

LinkOut - more resources